Understanding how amyloid proteins build up in Alzheimer's disease
Nanoscale assembly of amyloid oligomers at physiologically relevant conditions
This research aims to understand how tiny amyloid proteins gather together in the brain, which is a key process in Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11163361 on NIH RePORTER |
What this research studies
Scientists believe that the buildup of amyloid proteins in the brain is a major factor in Alzheimer's disease. However, previous laboratory studies often used much higher protein concentrations than what is found in the human brain, making it hard to see how these proteins form harmful clumps naturally. This project explores a new idea: that surfaces within the brain, like cell membranes, might act as catalysts, helping these proteins to clump together even at very low, natural concentrations. We believe that changes in the makeup of these membranes, possibly due to aging, could be a crucial factor in starting this protein buildup. By understanding this process, we hope to uncover new ways to prevent or slow down Alzheimer's disease.
Who could benefit from this research
Good fit: This foundational research is not recruiting patients, but future clinical applications may benefit individuals at risk for or in the early stages of Alzheimer's disease.
Not a fit: Patients with advanced Alzheimer's disease or those with other forms of dementia may not directly benefit from this specific basic science project.
Why it matters
Potential benefit: If successful, this work could reveal new targets for therapies that prevent the harmful buildup of amyloid proteins in the brains of people with Alzheimer's disease.
How similar studies have performed: This project proposes a novel mechanism for amyloid aggregation at physiological concentrations, building upon existing knowledge but exploring a new catalytic role for surfaces.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Lyubchenko, Yuri L — University of Nebraska Medical Center
- Study coordinator: Lyubchenko, Yuri L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.